169 related articles for article (PubMed ID: 27655286)
1. MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway.
Xiaohong Z; Lichun F; Na X; Kejian Z; Xiaolan X; Shaosheng W
Tumour Biol; 2016 Nov; 37(11):14989-14997. PubMed ID: 27655286
[TBL] [Abstract][Full Text] [Related]
2. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
4. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
Fu X; Cui Y; Yang S; Xu Y; Zhang Z
Tumour Biol; 2016 May; 37(5):6477-83. PubMed ID: 26631045
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
Xia Y; Gao Y
Biochem Biophys Res Commun; 2014 May; 447(3):446-51. PubMed ID: 24735543
[TBL] [Abstract][Full Text] [Related]
7. miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
Tan H; He Q; Gong G; Wang Y; Li J; Wang J; Zhu D; Wu X
Int J Oncol; 2016 Jan; 48(1):181-90. PubMed ID: 26575700
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
9. miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.
Lei L; Huang Y; Gong W
Oncol Rep; 2013 Dec; 30(6):2897-902. PubMed ID: 24084898
[TBL] [Abstract][Full Text] [Related]
10. The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.
Sun KX; Chen Y; Chen S; Liu BL; Feng MX; Zong ZH; Zhao Y
Oncotarget; 2016 Feb; 7(8):9236-49. PubMed ID: 26843615
[TBL] [Abstract][Full Text] [Related]
11. MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
Li R; Shi X; Ling F; Wang C; Liu J; Wang W; Li M
Tumour Biol; 2015 Sep; 36(9):7277-83. PubMed ID: 25895459
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
13. MiR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect.
Yang X; Zhao H; Yang J; Ma Y; Liu Z; Li C; Wang T; Yan Z; Du N
Biochem Biophys Res Commun; 2019 Jul; 515(1):85-91. PubMed ID: 31128917
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.
Zhang X; Liu J; Zang D; Wu S; Liu A; Zhu J; Wu G; Li J; Jiang L
Oncotarget; 2015 Jun; 6(17):15180-93. PubMed ID: 25893382
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression.
Li J; Hu K; Gong G; Zhu D; Wang Y; Liu H; Wu X
Sci Rep; 2017 Feb; 7():41330. PubMed ID: 28145479
[TBL] [Abstract][Full Text] [Related]
16. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-1 inhibits ovarian cancer cell proliferation and migration through c-Met pathway.
Qu W; Chen X; Wang J; Lv J; Yan D
Clin Chim Acta; 2017 Oct; 473():237-244. PubMed ID: 28698064
[TBL] [Abstract][Full Text] [Related]
18. miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA.
Han RL; Wang FP; Zhang PA; Zhou XY; Li Y
Neoplasma; 2017; 64(2):244-252. PubMed ID: 28043152
[TBL] [Abstract][Full Text] [Related]
19. Amplification of hsa-miR-191/425 locus promotes breast cancer proliferation and metastasis by targeting DICER1.
Zhang X; Wu M; Chong QY; Zhang W; Qian P; Yan H; Qian W; Zhang M; Lobie PE; Zhu T
Carcinogenesis; 2018 Dec; 39(12):1506-1516. PubMed ID: 30084985
[TBL] [Abstract][Full Text] [Related]
20. miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1.
Gong C; Yang Z; Wu F; Han L; Liu Y; Gong W
Oncol Rep; 2016 Oct; 36(4):2177-83. PubMed ID: 27499367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
